PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Mar-2023 PharmaSGP Holding SE releases forecast for full year 2023 PharmaSGP Holding SE
14-Mar-2023 Successful Update to Home Office Licence Celadon Pharmaceuticals Plc
14-Mar-2023 HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China HUTCHMED
14-Mar-2023 Ferring announces abstract of the first prospective, multi-national, realworld study of Rekovelle® (follitropin delta) at the congress of the Pacific Society for Reproductive Medicine Ferring Pharmaceuticals
14-Mar-2023 Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint achieved Acesion Pharma
14-Mar-2023 NTP Announces New Board Members & Executive Chairman to Spearhead Further Company Development and Internationalization B3C newswire
14-Mar-2023 Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit Sernova Corp.
14-Mar-2023 DEFENCE THERAPEUTICS SIGNS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER Defence Therapeutics Inc.
14-Mar-2023 Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray Marinomed Biotech AG
14-Mar-2023 Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time Dermapharm Holding SE
14-Mar-2023 Biotest AG: Biotest donates human albumin for earthquake victims in Turkey Biotest AG
14-Mar-2023 PolyPeptide reports weaker performance in 2022 – expects growth to recover in the second half of 2023 PolyPeptide
14-Mar-2023 Straumann Group launches digital solutions for dentistry at International Dental Show (IDS) in Cologne Straumann Holding AG
14-Mar-2023 Newron announces 2022 financial results and provides outlook for 2023 Newron Pharmaceuticals S.p.A.
14-Mar-2023 Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth Medartis Holding AG
13-Mar-2023 SYNLAB AG: Non-binding expression of interest by Cinven for acquisition offer at an indicative offer price of 10.00 Euro per SYNLAB share SYNLAB AG
13-Mar-2023 Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution ABIVAX
10-Mar-2023 Richard Stedman rejoins ACG as the CEO of Engineering Division ACG
09-Mar-2023 Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023 MorphoSys AG
09-Mar-2023 STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023 STRATEC SE